MarketBeat Earnings
Dominari (NASDAQ:DOMH) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen has downgraded Dominari (NASDAQ:DOMH) from "hold" to "sell," aligning with a reaffirmed "sell" rating from Weiss Ratings. The biotechnology company, which focuses on anticancer therapeutics, reported a quarterly loss of $0.21 per share on $16.79 million in revenue, beating analyst expectations. Despite this, Dominari shows significant financial weakness with a negative return on equity and …